Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 6, 1997, Pages 921-928

  Izuishi, Kunihiko ^a   Wakabayashi, Hisao ^a   Ohnishi, Taira ^a   Maeta, Hajime ^a   Maeba, Takashi ^a   Ichikawa, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cytocrome P 450; Drug metabolism; FK 506; Side effects; Tacrolimus

Indexed keywords

CYTOCHROME P450; ISOENZYME; TACROLIMUS;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; IN VITRO STUDY; LIVER MICROSOME; NONHUMAN; RAT; SPECTROPHOTOMETRY;

ANILINE HYDROXYLASE; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; KINETICS; MALE; MICROSOMES, LIVER; NADH, NADPH OXIDOREDUCTASES; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDOREDUCTASES; OXIDOREDUCTASES, O-DEMETHYLATING; RATS; RATS, SPRAGUE-DAWLEY; TACROLIMUS;

ANIMALIA;

EID: 0030872830     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(97)00027-7     Document Type: Article

References (20)

1. Ahmed S. S., Strobel H. W., Napoli K. L. and Grevel J. (1993) Adrenochrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J. Pharmacol. Exp. Ther. 265, 1047-1054.
2. Bargetzi M. J., Aoyama T., Gonzalez F. J. and Meyer U. (1989) Lidocaine metabolism in human liver microsomes by cytochrome P-450 IIIA4. Clin. Pharmacol. Ther. 46, 521-527.
3. Brodie B. B. and Axelrod J. (1948) Estimation of acetanilide and its metabolic products, aniline, N-acetyl p-aminophenol and p-aminophenol (free and total conjugated) in biological fluids and tissues. J. Pharmacol. Exp. Therap. 94, 22-28.
4. Ichikawa Y. and Yamano T. (1969) Studies on the microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase from rabbit liver. J. Biochem. 66, 351-360.
5. Imaoka S., Imai Y., Shimada T. and Funae Y. (1992) Role of phospholipids in reconstituted cytochrome P450 3A form and mechanism of their activation of catalytic activity. Biochemistry 31, 6063-6069.
6. Iwasaki K., Matsuda H., Nagase K., Shiraga T., Tokuma Y. and Uchida K. (1993) Effects of twenty-three drugs on the metabolism of FK-506 by human liver microsomes. Res. Commun. Chem. Pathol. Pharmacol. 82, 209-216.
7. Lampen A., Christians U., Guengerich F. P., Watkins P. B., Kolars J. C., Bader A., Gonschior A.-K., Dralle H. D., Hackbarth I. and Sewing K.-F. (1995) Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab. Dispos. 23, 1315-1324.
8. Lu A. Y. H. and West S. (1980) Multiplicity of mammalian microsomal cytochromes P-450. Pharmacol. Rev. 31, 277-295.
9. McInnes G. T. and Brodie M. J. (1988) Drug interactions that matter. A clinical reappraisal. Drugs 36, 83-110.
10. Mitoma C., Posner H. S., Reitz H. C. and Udenfriend S. (1956) Enzymatic hydroxylation of aromatic compounds. Arch. Biochem. Biophys. 61, 431-441.
11. Netter K. J. and Seidel G. (1964) An adaptively stimulated O-demethylating system in rat liver microsomes and its system in rat liver microsomes and its kinetic properties. J. Pharmacol. Exp. Ther. 146, 61-65.
12. Omar G., Shah I. A., Thomson A. W., Whiting P. H. and Burke M. D. (1991) FK 506 inhibition of cyclosporine metabolism by human liver microsomes. Transplant. Proc. 23, 934-935.
13. Ryan D. E. and Levin W. (1990) Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45, 153-239.
14. Sattler M., Guengerich F. P., Yun C.-H., Christians U. and Sewing K.-F. (1992) Cytochrome P-450 3A enzymes are responsible for biotransformation of FK-506 and rapamycin in man and rat. Drug Metab. Dispos. 20, 753-761.
15. Schelenberg K. A. and Hellerman L. (1958) Oxidation of reduced diphosphopyridine nucleotide. J. Biol. Chem. 231, 547-556.
16. Shiraga T., Matsuda H., Nagase K., Iwasaki K., Noda K., Yamazaki H., Shimada T. and Finae Y. (1994) Metabolism of FK 506, a potent immunosuppressive agent, by cytochrome P-450 3A enzymes in rat, dog, and human liver microsomes. Biochem. Pharmacol. 47, 727-735.
17. Starzl T. E., Thomson A. W., Todo S. and Fung J. (1991) Proceedings of the First International Congress on FK-506. Transplant. Proc. 23, 2709-3375.
18. Starzl T. E., Toda S., Fung J., Demetris A. J., Venkataramman R. and Jain A. (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet 28, 1000-1004.
19. Vincent S. H., Karanam B. V., Painter S. K. and Chiu S.-H. L. (1992) In vitro metabolism of FK-506 in rat, rabbit, and human liver microsomes: Identification of a major metabolite and of cytochrome P-450 3A as the major enzymes responsible for its metabolism. Arch. Biochem. Biophys. 294, 454-460.
20. Int. J. Biochem. Cell Biol. Vol. 29, No. 6, pp. 895-900. 1997